(Q37222603)

English

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

scientific article published on May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

P F Ambros

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

I M Ambros

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G M Brodeur

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Khan

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A Nakagawara

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G Schleiermacher

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

F Speleman

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

R Spitz

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

W B London

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A D J Pearson

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J M Maris

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

British Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1471-1482

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605014

0 references

Overall genomic pattern is a predictor of outcome in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Neuroblastoma: biological insights into a clinical enigma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

The International Neuroblastoma Pathology Classification (the Shimada system).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Special pattern of widespread neuroblastoma with a favourable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

6 September 2017

Prognostic significance of DNA di-tetraploidy in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

14 September 2017

ArrayCGH-based classification of neuroblastoma into genomic subgroups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

14 September 2017

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

14 September 2017

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

28 September 2017

The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

28 September 2017

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

26 June 2018

Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Quality assessment of genetic markers used for therapy stratification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694415

3 September 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605014

21 January 2018

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605014

21 January 2018

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605014

21 January 2018

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous regression of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different karyotypic patterns in early and advanced stage neuroblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of chromosome 1p loss of heterozygosity in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19401703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6605014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19401703%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37222603&oldid=2137290412"